-Maurizio Fava Researcher Activity Profile

Research Author Detailed Information 

Maurizio Fava Publication Rate By Year

Maurizio Fava has published 6 paper(s) in 2006, 36 paper(s) in 2007, 11 paper(s) in 2008, for a total of 53 research publications in total.

Maurizio M Fava Author Information

LAST NAME: fava

FIRST NAME: maurizio

INITIALS: M

AFFILIATION:

Papers

Maurizio Fava's Publication Record

1. Comparison of quality of life measures in a depressed population. Year Published: 2007
Epidemiology Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. wisniew@edc.pitt.edu
2. Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment. Year Published: 2007
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. rfaguas@partners.org
3. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Year Published: 2007
Department of Psychiatry, University of Pittsburgh Medical Center, 3811 OHara St., Pittsburgh, PA 15213-2593, and Massachusetts General Hospital, USA. thaseme@upmc.edu
4. Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Year Published: 2007
Department of Psychiatry, Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, and Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston, USA. wisniew@edc.pitt.edu
5. Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. Year Published: 2006
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. gpapakostas@partners.org
6. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. Year Published: 2006
VA Medical Center, Tuscaloosa, AL 35404, USA. lori.davis@med.va.gov
7. Recognizing and engaging depressed Chinese Americans in treatment in a primary care setting. Year Published: 2006
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. ayeung@partners.org
8. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Year Published: 2006
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9086, USA. john.rush@utsouthwestern.edu
9. Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. Year Published: 2006
Depression Clinical and Research Program, ACC 812, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 01224, USA. anierenberg@partners.org
10. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Year Published: 2006
Depression Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. rperlis@partners.org
11. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. mfava@partners.org
12. Use of treatment algorithms for depression. Year Published: 2007
13. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. gpapakostas@partners.org
14. Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
15. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Year Published: 2007
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7160, USA. bngaynes@med.unc.edu
16. Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data. Year Published: 2007
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9119, USA.
17. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Year Published: 2007
Massachusetts General Hospital, Boston, MA 02114, USA. rperlis@partners.org
18. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Year Published: 2007
Section on Molecular Genetics, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
19. Insured and non-insured depressed outpatients: how do they compare? Year Published: 2007
Department of Psychiatry, Harbor-UCLA Medical Center, The Los Angeles Biomedical Research Institute, Los Angeles, CA, USA. ILesser@ladhs.org
20. Major depressive disorder with anger attacks and cardiovascular risk factors. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, USA. rfraguas@hcnet.usp.br
21. Pain in depression: STAR*D study findings. Year Published: 2007
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-8898, USA. mustafa.husain@utsouthwestern.edu
22. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Year Published: 2007
Department of Psychiatry and Molecular and Behavioral Neurosciences Institute, University of Michigan, MBNI, 205 Zina Pitcher place, Ann Arbor, MI 48109-0720, and Massachusetts General Hospital, Boston 02114, USA. eayoung@umich.edu
23. Antidepressant dose reduction and the risk of relapse in major depressive disorder. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. 02114, USA. gpapakostas@partners.org
24. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, and Department of Psychiatry, University of Pittsburgh Medical Center, PA, USA. Mfava@Partners.org
25. The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study. Year Published: 2007
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.
26. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD. Year Published: 2007
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. afarabaugh@partners.org
27. Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. Year Published: 2007
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Harvard University, Boston, MA 02114, USA. rfraguas@partners.org
28. Effect of age at onset on the course of major depressive disorder. Year Published: 2007
Department of Psychiatry, University of California, San Diego, CA 92093, USA. szisook@ucsd.edu
29. Augmenting antidepressants with folate: a clinical perspective. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. mfava@partners.org
30. Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data. Year Published: 2007
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9119, USA.
31. Acupuncture for major depressive disorder: has its efficacy been disproved? Year Published: 2007
32. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Year Published: 2007
Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WAC 812, Boston, MA 02114, USA. gpapakostas@partners.org
33. Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study. Year Published: 2007
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. mcandrian@partners.org
34. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Year Published: 2007
Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA. gpapakostas@partners.org
35. Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. Year Published: 2007
Department of Veterans Affairs (VA) Medical Center, Tuscaloosa, Ala. 35404, USA. lori.davis@va.gov
36. Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. Year Published: 2007
Department of Veterans Affairs (VA) Medical Center, Tuscaloosa, Ala. 35404, USA. lori.davis@va.gov
37. The STAR*D Project results: a comprehensive review of findings. Year Published: 2008
Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9086, USA. Diane.Warden@UTSouthwestern.edu
38. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, and Department of Psychiatry, University of Pittsburgh Medical Center, PA, USA. Mfava@Partners.org
39. The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study. Year Published: 2007
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.
40. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Year Published: 2007
Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA. gpapakostas@partners.org
41. The STAR*D Project Results: A Comprehensive Review of Findings. Year Published: 2008
Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9086, USA. Diane.Warden@UTSouthwestern.edu.
42. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Year Published: 2007
Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Andrew.Kozel@utsouthwestern.edu
43. The STAR*D study: treating depression in the real world. Year Published: 2008
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599, USA. bgaynes@med.unc.edu
44. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. Year Published: 2007
Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. gpapakostas@partners.org
45. Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans. Year Published: 2008
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Behavioral Health, South Cove Community Health Center, Boston, MA 02111, USA.
46. Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression. Year Published: 2008
Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. rharley@partners.org
47. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Year Published: 2007
Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WAC 812, Boston, MA 02114, USA. gpapakostas@partners.org
48. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Year Published: 2008
Bristol-Myers Squibb, Wallingford, CT 06492, USA.
49. The STAR*D Project results: a comprehensive review of findings. Year Published: 2008
Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9086, USA. Diane.Warden@UTSouthwestern.edu
50. The impact of galantamine on cognition and mood during electroconvulsive therapy: A pilot study. Year Published: 2008
Massachusetts General Hospital, Inpatient Psychiatric Services, 55 Fruit Street, Warren 1220, Boston, MA 02114, United States.
51. Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Year Published: 2008
Division of Postgraduate Education, Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
52. A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: A STAR()D report. Year Published: 2008
School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
53. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Year Published: 2008
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. gpapakostas@partners.org